Ordinary Rebalance | Solactive Obesity Index | Effective Date 1st February 2023
In the ordinary rebalance, the following index composition will be implemented effective open 01.02.2023:
| ADAPTHEALTH CORP |
| ALTIMMUNE INC |
| ANGIODYNAMICS INC |
| ARTIVION INC |
| BIONIME CORP |
| CARDIOVASCULAR SYSTEMS INC |
| CATO CORP-CLASS A |
| CVRX INC |
| DARIOHEALTH CORP |
| DEXCOM INC |
| EKF DIAGNOSTICS HOLDINGS PLC |
| ESPERION THERAPEUTICS INC |
| FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED |
| HERBALIFE NUTRITION LTD |
| HUA MEDICINE |
| I-SENS INC |
| INSPIRE MEDICAL SYSTEMS INC |
| INSULET CORP |
| IRHYTHM TECHNOLOGIES INC |
| LEMAITRE VASCULAR INC |
| LEXICON PHARMACEUTICALS INC |
| LIFETECH SCIENTIFIC CORP |
| MADRIGAL PHARMACEUTICALS INC |
| MANNKIND CORP |
| MEDIFAST INC |
| MICROPORT SCIENTIFIC CORP |
| N BROWN GROUP PLC |
| NIPRO (NISSHO) CORP ORD |
| NOVAREX CO LTD |
| NOVO NORDISK A/S |
| RESMED INC-CDI |
| RHYTHM PHARMACEUTICALS INC |
| SD BIOSENSOR INC |
| SENSEONICS HOLDINGS INC |
| TAIDOC TECHNOLOGY CORP |
| TANDEM DIABETES CARE INC |
| TCI CO LTD |
| TEVA PHARMACEUTICAL IND LTD |
| USANA HEALTH SCIENCES INC |
| WW INTERNATIONAL INC |